| story_key |
isk_0c50df23a56be86fdd73 |
| entity_key |
equity:CNBC |
| theme_key |
world_news |
| latest_story_id |
intel_afc4133af408fc52 |
| first_seen_at |
2026-04-13T14:48:45+00:00 |
| last_seen_at |
2026-04-13T14:48:45+00:00 |
| last_alerted_at |
NULL |
| last_digested_at |
NULL |
| last_decision |
monitor |
| last_alert_class |
none |
| continuity_state |
new |
| uncertainty_state |
conflicted |
| followup_status |
none |
| followup_attempts |
0 |
| last_followup_at |
NULL |
| last_verification_note |
Validate the primary claim against at least one pr Validate the primary claim against at least one primary source.... |
| last_confidence |
0.46 |
| last_corroboration_score |
0.3425 |
| last_importance_score |
0.5778 |
| last_provenance_score |
0.7131 |
| quality_delta |
0.4858 |
| latest_headline |
Revolution Medicines' potential breakthrough p Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial - CNBC... |
| latest_thesis |
Revolution Medicines' potential breakthrough p Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial - CNBC... |
| latest_why_now |
1 signal families across 8 sources converged withi 1 signal families across 8 sources converged within the last few hours (latest signal at 2026-04-13T14:48:45+00:00).... |
| unresolved_questions |
["Validate the primary claim against at least ["Validate the primary claim against at least one primary source.","Confirm the same claim type across another independent source family.","Check timing context and unresolved uncertainty before escalation.","Resolve contradiction: directional claim conflict","Resolve contradiction: claim type conflict:news development"]... |
| seen_timestamps_30d |
["2026-04-13T14:48:45+00:00"] |
| surfaced_timestamps_30d |
[] |
| alerted_timestamps_30d |
[] |
| seen_count_total |
1 |
| surfaced_count_total |
0 |
| alert_count_total |
0 |
| updated_at |
2026-04-13T16:38:51.265546+00:00 |